In addition to their therapeutic applications, glucocorticosteroids have been widely used and abused in the belief that these substances may enhance athletic performance. Analysis of athlete urine samples by antidoping laboratories around the world support this conclusion. It is commonly accepted in medical practice to use local glucocorticosteroid injections in the treatment of non-infectious local musculotendinous inflammatory conditions conveying symptom relief and often a speedier return to sporting activity. This practice is not to be considered illicit, but sports physicians must accept that such an intervention is not in itself an immediate cure and that an athlete will still require a period of recuperation before continuing sporting activity. How long such a period of recuperation should last is a matter of conjecture and there is little concrete data to support what is, or what is not, an acceptable period of inactivity. In the interest of athlete safety, we would propose to maintain systemic glucocorticosteroids on the World Anti-Doping Agency's (WADA) list of prohibited substances, both in and out-of-competition as well as a mandatory period of 48 hours of rest from play after receiving a local glucocorticosteroid injection.
AngeliAMinettoMDovioAPaccottiP. The overtraining syndrome in athletes: A stress-related disorder. J Endocrinol Invest2004; 27:603–12.
2.
BarnesPJ. Anti inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci1998; 94:557–72.
3.
WehlingM. Specific Non genomic actions of steroid hormones. Ann Rev Physiol1997; 59:365–93.
4.
BeatoMTrussMChavezS. Control of transcription by steroid hormones. Ann NY Acad Sci1996; 784: 93–123.
5.
CharronJDrouinJ. Glucocorticoid inhibition of transcription from episomal proopiomelanocortin gene promoter. Proc Natl Acad Sci USA1986; 83: 8903–7.
6.
RayAPrefontaineKE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA1994; 91:752–6.
7.
NewtonR. Molecular mechanisms of glucocorticoid action: What is important?Thorax2000; 55:603–13.
8.
MoghadamAHSimonciniTYangZ. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med2002; 8: 473–9.
9.
RogoffJMStewartGN. The influence of adrenal extracts on the survival period of adrenalectomized dogs. Science1927; 66:327.
10.
FinemanEH. The use of suprarenal cortex extract in the treatment of bronchial asthma. J Allerg1932; 4: 182–90.
11.
CareyRAHarveyAMHowardJEWinkenwerderWL. The effect of adrenocorticotropic hormone (ACTH) and cortisone on the course of chronic bronchial asthma. Bull John Hopkins Hosp1950; 87: 387–414.
12.
RhenTCidlowskiJA. Antiinflammatory action of glucocorticoids. New Mechanisms for old drugs. N Engl J Med2005; 353:1711–23.
13.
KeithBD. Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy. BMC Cancer2008; 28:84–103.
14.
CollompKArlettazAPortierHLecoqAMLe PanseBRiethNDe CeaurrizJ. Short-term glucocorticoid intake combined with intense training on performance and hormonal responses. Br J Sports Med2008; 42:983–8.
15.
MinettoMRainoldiAGazzoniM. Differential responses of serum and salivary interleukin-6 to acute strenuous exercise. Eur J Appl Physiol2005; 93:679–86.
16.
DuclosMGouarneCBonnemaisonD. Acute and chronic effects of exercise on tissue sensitivity to glucocorticoids. J Appl Physiol2003; 94:869–75.
17.
PiazzaPVRouge-PontFDerocheVMaccariSSimonHLe MoalM. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci USA1996; 93:8716–20.
18.
DuclosM. Glucocorticoids: A doping agent?Endocrinol Metab Clin N Am2010; 39:107–26.
19.
KuipersHVan't HullenaarGAPluimBMOverbeekSEDe HonOVan BredaEJVan LoonLC. Four weeks' corticosteroid inhalation does not augment maximal power output in endurance athletes. Br J Sports Med2008; 42:568–71.
20.
BaumeNSteelGEdwardsTThorstensedEMillerBF. No variation of physical performance and perceived exertion after adrenal gland stimulation by synthetic ACTH (Synacthen) in cyclists. Eur J Appl Physiol2008; 104:589–600.
21.
Le PanseBThomassonRJollinLLecoqAMAmiotVRiethNDe CeaurrizJCollompK. Short-term glucocorticoid intake improves exercise endurance in healthy recreationally trained women. Eur J Appl Physiol2009; 107:437–43.
22.
ThomassonRRiethNJollinLAmiotVLasneFCollompK. Short-term glucocorticoid intake and metabolic responses during long-lasting exercise. Horm Metab Res2011; 43:216–22.
23.
SoetensEDeMKHuetingJE. No influence of ACTH on maximal performance. Psychopharmacology1995;118:260–6.
24.
WoolfAD. An update on glucocorticoid-induced osteoporosis. Curr Opin Rheumatol2007; 19:370–5.
25.
SchakmanOGilsonHKalistaSThissenJP. Mechanisms of muscle atrophy induced by glucocorticoids. Horm Res2009; 72(S):36–41.
26.
MarquesAHSilvermanMNSternbergEM. Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics. Ann NY Acad Sci2009; 1179:1–18.
27.
NussinovitchUde CarvalhoJFPereiraRMShoenfeldY. Glucocorticoids and the cardiovascular system: State of the art. Curr Pharm Des2010; 16: 3574–85.
28.
LinHCasaleTB. Treatment of allergic asthma. Am J Med2002;113(S):8–16.
29.
MoriFBarniSPucciNRossiMEBattagliniC OrsiNovembreE. Upper airways disease: Role of corticosteroids. Int J Immunopathol Pharmacol2010; 23:61–6.
